| Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897) |
|---|
| 08/26/2003 | US6610866 Reacting unsaturated alkyl ketone with chiral oxazaborolidine compound to form unsaturated alkyl alcohol; intermediates for production of squalamine |
| 08/21/2003 | US20030158429 Method for obtaining or recovering sterols and tocopherols |
| 08/21/2003 | US20030158167 2-substituted ring A aromatic sterol derivatives having a comparatively short 17-position hydrocarbyl side chain terminates in an carboxaldehyde or hydroxy group; antiproliferative and antiangiogenic agent |
| 08/21/2003 | US20030158161 Administering to the human patient or non- human animal an effective amount of a substituted spirostan derivative to treat neurodegenerative disorders |
| 08/20/2003 | CN1118473C Aqueous soluble steroid compound alkaloid salt, producing process and medicinal composition containing same |
| 08/20/2003 | CN1118472C Method of extracting ergosterol from waste mycelium |
| 08/19/2003 | US6608220 Reacting with a hypochlorite in prescence of 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and a bromide |
| 08/19/2003 | US6608074 Administering during follicular phase of female menstrual cycle and in luteal phase, a competitive progesterone antagonist, which is less than an ovulation-inhibiting dose and less than an abortion-inductive dose |
| 08/14/2003 | US20030153541 Liver X receptor modulator comprising an oxysterol, lipid regulating HMG-CoA reductase inhibitor, fibric acid derivative, niacin, bile-acid sequestrant, probucol, raloxifene, unsaturated omega-3 fatty acid |
| 08/13/2003 | CN1436170A Vitamin D derivs. |
| 08/07/2003 | WO2003064444A1 Fractionation of phytosterol esters in oil |
| 08/07/2003 | WO2003064442A2 Distalliative process of extracting and purifying phytosterols and phytostanols from tall oil pitch |
| 08/07/2003 | US20030149287 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 08/07/2003 | US20030148962 For therapy of ischemic cerebral-vascular diseases |
| 08/07/2003 | CA2474592A1 Distalliative process of extracting and purifying phytosterols and phytostanols from tall oil pitch |
| 08/07/2003 | CA2473250A1 Fractionation of phytosterol esters in oil |
| 07/31/2003 | US20030144536 Feeding the pitch into a first distillation column; distilling the pitch to remove excess rosin acids and fatty acids to form a distilled pitch; saponifying the distilled pitch with an aqueous solution of one or more alkali metal bases to form a |
| 07/30/2003 | EP1180035A4 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1$g(a), 25-DIHYDROXY VITAMIN D 3? |
| 07/30/2003 | CN1432579A Refining process of chenodeoxcholic acid |
| 07/24/2003 | WO2003059366A1 Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient |
| 07/24/2003 | US20030139616 Alcohol extraction to remove intracellular free cholesterol |
| 07/24/2003 | US20030139385 Method of treating disorder related to high cholesterol concentration |
| 07/22/2003 | US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
| 07/17/2003 | US20030134833 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 07/16/2003 | EP1235579B1 Pharmaceutical compositions comprising trimegestone |
| 07/16/2003 | CN1114612C Process for synthesizing long-acting rapin lactones |
| 07/15/2003 | US6593319 Fusidic acid derivatives |
| 07/15/2003 | CA2086221C Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent |
| 07/10/2003 | US20030130246 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 07/09/2003 | EP1325928A1 Process for the preparation of pregnane derivatives |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/08/2003 | US6589946 Bile salt conjugates |
| 07/08/2003 | US6589588 For lowering the absorption of cholesterol from the digestive tract; sterol and/or stanol fatty acid ester composition, wherein the fatty acid moiety comprises blend of less 7% saturated fatty acids and more than 50% polyunsaturated |
| 07/02/2003 | EP1322315A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 07/02/2003 | EP1056767B1 Method for the preparation of phytosterols from tall oil pitch |
| 07/01/2003 | US6586201 Method of chromatographic isolation for non-glyceride components |
| 06/25/2003 | CN1426305A Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract |
| 06/25/2003 | CN1112366C Extracting method of ginsenoside |
| 06/19/2003 | WO2003039480A3 Method of treating disorder related to high cholesterol concentration |
| 06/19/2003 | US20030113361 Palatable arginine compounds and uses thereof for cardiovascular health |
| 06/18/2003 | CN1424321A Extraction of panax notoginseng leaf saponine |
| 06/18/2003 | CN1424320A Hemsleyadine derivative and its preparing method and use as bactericidal agent |
| 06/17/2003 | US6579864 Arthritic diseases and/or autoimmune diseases |
| 06/12/2003 | WO2003048182A1 Use of totle saponins compounds and a pharmaceutical composition containing totle saponins compounds |
| 06/12/2003 | US20030109729 Process control; controlling length of passageways, times, temperature |
| 06/12/2003 | US20030109699 Biopolymers; gene therapy, medical diagnosis |
| 06/11/2003 | CN1422861A Use of saponin |
| 06/11/2003 | CN1111169C Sterol derivatives, synthesis method and use thereof |
| 06/11/2003 | CN1111168C Supercritical fluid extraction method of high-purity sterol |
| 06/11/2003 | CN1111167C 3 beta-hydroxy-5-cholenic acid ester derivatives, synthesis process and use thereof |
| 06/05/2003 | US20030104360 Synthetic receptors, libraries and uses thereof |
| 06/04/2003 | EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 06/04/2003 | CN1422253A Carbamate caspase inhibitors and uses thereof |
| 06/04/2003 | CN1110501C Cholesterol acetate extracted from sponge and its preparation |
| 05/28/2003 | EP1232173B1 Fusidic acid derivatives |
| 05/22/2003 | US20030097011 Novel carbamate-based cationic lipids |
| 05/22/2003 | US20030096800 Estrogenic compounds as anti-mitotic agents |
| 05/21/2003 | EP1311531A1 Steroid derived antibiotics |
| 05/15/2003 | WO2003040066A1 Chemical synthesis |
| 05/15/2003 | WO2003039480A2 Method of treating disorder related to high cholesterol concentration |
| 05/15/2003 | CA2466033A1 Method of treating disorder related to high cholesterol concentration |
| 05/14/2003 | EP0830369B1 Nor-pregnanes for inducing hypothalamic effects |
| 05/14/2003 | CN1418221A Process for producing diels-alder adducts of sterol 5,7-dienes using unsaturated fatty acid catalyst |
| 05/14/2003 | CN1108306C New saponin compound and its preparation method and application |
| 05/13/2003 | US6562946 Human procalcitonin and the preparation and use thereof |
| 05/13/2003 | US6562805 Compositions for inhibiting effective binding of a chemokine to its cellular recepto |
| 05/08/2003 | WO2003037354A1 USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER |
| 05/08/2003 | US20030087836 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 05/08/2003 | US20030087789 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 05/02/2003 | EP1305022A1 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures |
| 05/02/2003 | EP0831837B1 Use of squalamine for the manufacture of a medicament for inhibiting nhe |
| 05/01/2003 | WO2003035669A1 Amphiphilic cationic lipids derived from cholesterol |
| 05/01/2003 | US20030083323 Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulators |
| 05/01/2003 | US20030082154 Fusogenic lipids and vesicles |
| 04/30/2003 | CN1414009A Method for extracting and separating notoginsenoside R1, panaxcoside Re, pseudo-ginseng element from pseudo-ginseng crude powder |
| 04/29/2003 | US6555531 Weight promoting composition, method, and product |
| 04/24/2003 | WO2002079219A3 Anti-proliferative 6-o-acyl-beta-d-glucosyl-beta-sitosterol compounds |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/23/2003 | EP0946584B1 Meiosis regulating compounds |
| 04/23/2003 | CN1412163A Preparation method of total saponin and flavone extract in notoginseng leaf |
| 04/23/2003 | CN1412162A Preparation method of total saponin extract in notoginseng leaf |
| 04/22/2003 | US6552011 (Androst-5-en-17beta -yl)alkyl sulfoxides and sulfones and their use for control of fertility |
| 04/16/2003 | EP1301460A1 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 04/16/2003 | CN1411466A Compound (I), method for extracting it and pharmaceutical composition containing it |
| 04/16/2003 | CN1105781C Method for preparing rare ginsengoside using enzymatic method to modify ginsengoside glycoside |
| 04/10/2003 | WO2003020214A3 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 04/10/2003 | US20030069214 Process for preparing saponin compounds |
| 04/09/2003 | EP1075191B1 Phytosterol compositions |
| 04/08/2003 | US6544973 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 04/08/2003 | CA2048243C 4-amino- 4,6-steroids and their use as 5-.alpha.-reductase inhibitors |
| 04/03/2003 | WO2003027133A1 Cohalogenations of selected double bonded compounds using n-halo-succinimide. |
| 04/03/2003 | WO2003026672A1 A method of reducing the in vivo cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (hdl) and low density lipoproteins (ldl) |
| 04/03/2003 | WO2003007323A3 Method for preparing organic, in particular lithocholic acid, nanotubes and uses thereof |
| 04/03/2003 | CA2461136A1 A method of reducing the in vivo cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (hdl) and low density lipoproteins (ldl) |
| 04/02/2003 | EP1298194A2 Stanol comprising compositions |
| 04/02/2003 | EP1124841B1 Substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 04/02/2003 | EP0738157B1 Contrast media for x-ray and magnetic resonance imaging |
| 04/01/2003 | US6541463 Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use |
| 03/26/2003 | EP1295871A1 Vitamin d derivatives |
| 03/26/2003 | CN1405176A Steride, its systhesis method and use |